| Device |
gabapentin assay |
| Regulation Description |
Diphenylhydantoin test system. |
| Definition |
Test for the quantitative determination of gabapentin in human serum or plasma. Gabapentin concentrations can be used as an aid in management of patients treated with gabapentin. |
| Physical State |
Liquid reagents |
| Technical Method |
Quantitative, Homogenous Enzyme Immunoassay |
| Target Area |
in vitro diagnostic |
| Regulation Medical Specialty |
Toxicology |
| Review Panel |
Toxicology |
| Product Code | OTF |
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Chemistry and Toxicology Devices
(DCTD)
|
| Submission Type |
510(k)
|
| Regulation Number |
862.3350
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
|
Third Party Review
|
Accredited Persons
|